Growth Metrics

Evaxion A (EVAX) Treasury Shares (2022 - 2023)

Evaxion A posted quarterly Treasury Shares of $4.4 million for Q2 2023, up 14.2% year-on-year from $3.8 million in Q2 2022, and up 4.1% on a QoQ basis from $4.2 million in Q1 2023.

Evaxion A (EVAX) has 2 years of Treasury Shares data on file, last reported at $4.4 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 265,401.92
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 700,000.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 34.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Revolution Medicines 32.39 Bn 32.39 Bn - 5.14 Mn

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 4.39 Mn
Jun 30, 2023 4.39 Mn
Mar 31, 2023 4.22 Mn
Mar 31, 2023 4.22 Mn
Jun 30, 2022 3.84 Mn
Jun 30, 2022 3.84 Mn